Santa Clara, California, United States The main office of represented VC is situated in the Santa Clara. The venture was found in North America in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Medical Device, Medical. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline APT Pharmaceuticals, CoMentis, Corepair
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Charter Life Sciences, startups are often financed by Versant Ventures, Venrock, Rev1 Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, MB Venture Partners, EDBI. In the next rounds fund is usually obtained by Rev1 Ventures, Radius Ventures, Canaan Partners.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2017. The high activity for fund was in 2013. Considering the real fund results, this VC is 3 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Charter Life Sciences performs on 6 percentage points less the average number of lead investments.
We also calculated 4 valuable employees in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| ABR Capital Management | California, San Francisco, United States |
| Balyasny Asset Management | Chicago, Illinois, United States |
| Beijing Falcon Investment | Beijing, Beijing, China |
| BGA Invest AB | Lund, Skane Lan, Sweden |
| Center for Innovation | Arlington, Texas, United States |
| Christie Digital Systems USA | California, Cypress, United States |
| Cogene Ventures | Houston, Texas, United States |
| DAYU CAPITAL | China, Guangdong Province, Longgang District |
| Dazhong Group | China, Dongguang, Guangdong |
| Goldfish Fund | Lithuania, Vilniaus Apskritis, Vilnius |
| HCM Capital | China, Shanghai |
| Mountain Top | Beijing, Beijing, China |
| One Planet | California, United States, Walnut Creek |
| Oxygen Capital Partners, LLC | California, Santa Monica, United States |
| Radar Capital | - |
| RevRoad | Provo, United States, Utah |
| Tsukuba Exceed Fund | - |
| Wyre Capital | California, San Francisco, United States |
| Zen Group | Attica, Greece, Municipal Unit of Cholargos |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Xlumena | $25M | 03 Dec 2013 | Mountain View, California, United States | ||
Amaranth Medical | $20M | 08 Oct 2013 | Mountain View, California, United States | ||
Minimally invasive devices | $2M | 17 Jun 2013 | Columbus, Ohio, United States | ||
Minimally invasive devices | $9M | 25 Mar 2013 | Columbus, Ohio, United States | ||
Xlumena | $7M | 29 Apr 2011 | Mountain View, California, United States | ||
Prevacept Infection Control | $3M | 23 Aug 2010 | Colorado, United States | ||
Corepair | $4M | 30 Apr 2010 | Sunnyvale, California, United States | ||
Inviragen | $15M | 06 Oct 2009 | Fort Collins, Colorado, United States | ||
Revascular Therapeutics | $3M | 11 May 2009 | Sunnyvale, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Xlumena | $25M | 03 Dec 2013 | Mountain View, California, United States | ||
Amaranth Medical | $20M | 08 Oct 2013 | Mountain View, California, United States | ||
Minimally invasive devices | $2M | 17 Jun 2013 | Columbus, Ohio, United States | ||
Minimally invasive devices | $9M | 25 Mar 2013 | Columbus, Ohio, United States | ||
Xlumena | $7M | 29 Apr 2011 | Mountain View, California, United States | ||
Prevacept Infection Control | $3M | 23 Aug 2010 | Colorado, United States | ||
Corepair | $4M | 30 Apr 2010 | Sunnyvale, California, United States | ||
Inviragen | $15M | 06 Oct 2009 | Fort Collins, Colorado, United States | ||
Revascular Therapeutics | $3M | 11 May 2009 | Sunnyvale, California, United States |
